A share price of Surmodics, Inc [SRDX] is currently trading at $36.89, down -1.52%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SRDX shares have lost -2.92% over the last week, with a monthly amount glided 22.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Surmodics, Inc [NASDAQ: SRDX] stock has seen the most recent analyst activity on March 07, 2025, when Lake Street upgraded its rating to a Buy but kept the price target unchanged to $43 for it. Previously, Needham upgraded its rating to Buy on June 13, 2023, and kept the price target unchanged to $36. On February 13, 2023, downgrade downgraded it’s rating to Hold. Needham upgraded its rating to a Buy. Needham downgraded its rating to a Hold. Lake Street downgraded its rating to Hold for this stock on November 01, 2019, and downed its price target to $50. In a note dated August 01, 2019, Needham reiterated a Buy rating on this stock and boosted its target price from $65 to $68.
Surmodics, Inc experienced fluctuations in its stock price throughout the past year between $26.00 and $40.38. Currently, Wall Street analysts expect the stock to reach $39.5 within the next 12 months. Surmodics, Inc [NASDAQ: SRDX] shares were valued at $36.89 at the most recent close of the market. An investor can expect a potential return of 7.08% based on the average SRDX price forecast.
Analyzing the SRDX fundamentals
Trailing Twelve Months sales for Surmodics, Inc [NASDAQ:SRDX] were 120.80M which represents -2.55% decline. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.1%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is -0.15%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.16 and Total Capital is -0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.39 points at the first support level, and at 35.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.51, and for the 2nd resistance point, it is at 38.12.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Surmodics, Inc [NASDAQ:SRDX] is 3.91. As well, the Quick Ratio is 3.10, while the Cash Ratio is 1.35. Considering the valuation of this stock, the price to sales ratio is 4.37, the price to book ratio is 4.74.
Transactions by insiders
Recent insider trading involved Arens Timothy J., Chief Financial Officer, that happened on Nov 26 ’24 when 7009.0 shares were sold. Officer, TIMOTHY ARENS completed a deal on Nov 26 ’24 to buy 7009.0 shares.
